These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 16772121)
1. [A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review]. Xie Y; Zhao WH; Hua Y; Sun Q; Wu PH Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1263-1266. PubMed ID: 29237527 [TBL] [Abstract][Full Text] [Related]
2. Revisiting the indication for prophylactic contralateral mastectomy in patients with Li-Fraumeni syndrome and breast cancer. Case report. Briceño-Morales X; Briceño-Morales C; Guerrero-Macías SI; Pedroza-Durán AM; Súarez-Rodríguez RA Rev Colomb Obstet Ginecol; 2021 Sep; 72(3):307-318. PubMed ID: 34851573 [TBL] [Abstract][Full Text] [Related]
3. Pleomorphic dermal sarcoma presenting in a child with Li-Fraumeni syndrome: A case report and review of the literature. Kim H; Noh H; Shim J; Oh SJ; Lee JH; Lee DY; Park JH Pediatr Dermatol; 2024; 41(2):311-314. PubMed ID: 38014598 [TBL] [Abstract][Full Text] [Related]
4. The Role of Radiation Therapy in Locally Advanced Breast Cancer in a Patient With Li-Fraumeni Syndrome. Roberts AC; Lunt LG; Coogan AC; Madrigrano A Am Surg; 2023 Nov; 89(11):4958-4960. PubMed ID: 36420590 [TBL] [Abstract][Full Text] [Related]
5. Therapy-related Myeloid Neoplasms in Children: A Single-institute Study. Li G; Holly T; Kelly DR; Reddy V; Mikhail FM; Carroll AJ; Kutny MA J Pediatr Hematol Oncol; 2022 Jan; 44(1):e109-e113. PubMed ID: 33625084 [TBL] [Abstract][Full Text] [Related]
6. The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder. Yao Z; Sherif ZA Oncotarget; 2016 Sep; 7(39):62976-62988. PubMed ID: 27542210 [TBL] [Abstract][Full Text] [Related]
7. Caspase Activation and Aberrant Cell Growth in a p53(+/+) Cell Line from a Li-Fraumeni Syndrome Family. Sherif ZA Genet Res Int; 2015; 2015():789201. PubMed ID: 25866679 [TBL] [Abstract][Full Text] [Related]
8. Secondary Acute Lymphoblastic Leukemia after Hodgkin's Lymphoma or a Coincidental Association of Two Hematological Malignancies? Tevet M; Dragan C; Saguna C; Barbu D; Lupu AR Maedica (Bucur); 2013 Sep; 8(4):370-6. PubMed ID: 24790671 [TBL] [Abstract][Full Text] [Related]
9. Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer. Varadarajan R; Ford L; Sait SN; Block AW; Barcos M; Wallace PK; Ramnath N; Wang ES; Wetzler M Leuk Res; 2009 Sep; 33(9):1208-11. PubMed ID: 19181380 [TBL] [Abstract][Full Text] [Related]
10. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases. Shivakumar R; Tan W; Wilding GE; Wang ES; Wetzler M Ann Oncol; 2008 Sep; 19(9):1634-8. PubMed ID: 18467310 [TBL] [Abstract][Full Text] [Related]
11. Three germline mutations in the TP53 gene. Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756 [TBL] [Abstract][Full Text] [Related]
12. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation]. Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780 [TBL] [Abstract][Full Text] [Related]
13. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review. Soussi T; Leblanc T; Baruchel A; Schaison G Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038 [TBL] [Abstract][Full Text] [Related]
14. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Evans SC; Lozano G Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689 [TBL] [Abstract][Full Text] [Related]
15. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. Sherif ZA; Danielsen M Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121 [TBL] [Abstract][Full Text] [Related]
16. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079 [TBL] [Abstract][Full Text] [Related]